Lefamulin最初由Nabriva开发,2018年3月仑胜医药获得在大中华区,包括中国大陆、香港、澳门、台湾开...查看全文
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 内部交易: 2017-06-15,Director,Talbot George Harrison ,卖出,100普通股, $94.10
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 8-K - Current report Filed: 2017-06-19 AccNo: 0001104659-17-040061 Size: 7 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ SC 14D9/A [Amend] - Solicitation, recommendation statements Filed: 2017-06-09 AccNo: 0001104659-17-038441 Size: 52 KB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ SC TO-T/A [Amend] - Tender offer statement by Third Party Filed: 2017-06-09 AccNo: 0001104659-17-038440 Size: 50 KB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 425 - Prospectuses and communications, business combinations Filed: 2017-06-09 AccNo: 0001104659-17-038439 Size: 44 KB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 8-K - Current report Filed: 2017-06-09 AccNo: 0001104659-17-038438 Size: 44 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 425 - Prospectuses and communications, business combinations Filed: 2017-06-09 AccNo: 0001104659-17-038432 Size: 24 KB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 内部交易: 2017-06-01,10% Owner,HBM Healthcare Investments (Ca ,卖出,400普通股, $11.27
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 内部交易: 2017-05-30,Director,Talbot George Harrison ,卖出,210普通股, $101.26
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 8-K - Current report Filed: 2017-05-31 AccNo: 0001104659-17-036570 Size: 42 KBItem 4.01: Changes in Registrant's Certifying AccountantItem 9.01: Financial Statements and Exhibits 网页链接